Bordetella bronchiseptica Infection and Kennel Cough in Dogs

Monika Bhardwaj, Bhoj Raj Singh^*, Prasanna Vadhana

*Corresponding author:[email protected]

ARTICLE CITATION: Bhardwaj M, Singh BR and Vadhana P (2013). Bordetella bronchiseptica infection and kennel cough in dogs. Adv. Anim. Vet. Sci. 1 (3S): 1 – 4.
Received: 2013–10–01, Revised: 2013–10–14, Accepted: 2013–10–20
The electronic version of this article is the complete one and can be found online at ( http://nexusacademicpublishers.com/table_contents_detail/4/116/html ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

ABSTRACT

Among various pet animals, dogs have been men’s best companion and sharing the common dwellings. Recent analysis indicated that in India’s dog population has increased by 58% since 2007. Therefore, concern for diseases of dogs has also increased. The dogs often suffer from many diseases due to various managerial practices. One of such diseases is Bordetellosis often synonymous with kennel cough. Kennel cough is multi–etiological disease but Bordetella bronchiseptica, a gram negative bacterium, has been considered the main causative agent. It causes canine infectious bronchitis characterized by frequent dry and hacking coughing with high morbidity (~ 80%). This organism has also reported to cause zoonotic infections in human beings. Though a well studied disease of dogs, little is understood about its epidemiology in developing countries including India. The PCR and ELISA are the common diagnostic methods for Bordetella bronchiseptica infection. However, detection of the pathogen does not mean the disease and many of the cases of kennel cough may not be associated with bordetellosis. Further studies are necessary to understand its epidemiology in developing countries for proper management of kennel cough and other related problems.

Dog, an affectionate and loyal pet learns rapidly to live with its master with all his good and bad vices and is prone to acquire even the human diseases. Dogs’ population in India was around 10.2 millions in 2012 (Bradley and Kingnov, 2012) and is increasing rapidly with change in socio–economic structure in India. In India, pup population increased by 58% during 2007 to 2012 (Euromonitor International). Increase in population means more diseases, more attention and more expense. There are several diseases of pet dogs which make them suffer silently but respiratory infections are nuisance to their owners too. Moreover, with every cough, germs contaminate the environment and cough sounds also disturb the owners’ peace. The common respiratory infections of canines include canine influenza, canine distemper, parasitic infestations (Dirofilaria immitis, Trichuris vulpis), blastomycosis, histoplasmosis, coccidioidiomycosis and canine infectious tracheobronchitis (kennel cough). Among the cough causing infectious diseases bordetellosis, often synonymous to kennel cough, is one of the most prevalent respiratory infections of dogs. Kennel cough characterized by frequent dry and hacking coughing high morbidity but low mortality rate. Kennel cough is a multi–etiological disease but Bordetella bronchiseptica, the causal organism of bordetellosis in dogs, is considered to be the main etiologic agent.

Canine infectious tracheobronchitis or kennel cough affects dogs of all ages. It is more common in dogs housed together in re–homing centres, boarding or training kennels, pet shops, shelters and veterinary clinics than in individually owned and stray dogs. The primary etiologies are Bordetella bronchiseptica, Canine Adenovirus (Bulut et al., 2013) and Canine Parainfluenza virus (Erles et al. 2004). Some secondary agents including Mammalian Reo virus, Canine respiratory Corona virus, CAV type 1 (CAV–1), Canine Herpes virus, Mycoplasma sp., Pseudomonas sp., Pasteurella sp., Streptococcus sp., and coliforms invading after some primary sickness may also induce the symptoms of kennel cough. More specifically, Streptococcus equi subsp. zooepidemicus and Mycoplasma cynosare often involved in causation of the disease which last much longer and more serious than the one caused by primary pathogens (Chalker et al., 2003 & 2004; Rycroft et al., 2007).

Bordetella bronchiseptica, a Gram–negative bacterium, colonizes the respiratory tract of wide range of mammalian hosts including dogs, pigs, cats, rabbits, mice, rats, guinea pigs, sheep, horses and bears (Lennox and Kelleher, 2009). The interspecies transmission of B. bronchiseptica has been reported among laboratory animals and between a rabbit and a human patient. It may be transmitted between cats and dogs living in close proximity and results in respiratory disease. It has already showed by few researchers that isolates from dogs and cats living in close proximity gave similar banding patterns in pulsed field gel electrophoresis.

Besides B. bronchiseptica, Canine Adenovirus type 2 is one of the other major etiologies of kennel cough (Bulut et al., 2013). The virus replicates in non–ciliated bronchiolar epithelial cells, nasal mucosa, pharynx, tonsillar crypts, mucous cells in the bronchi and trachea in peribronchial glands and type 2 alveolar epithelial cells which results in interstitial pneumonia, necrotizing bronchitis or bronchiolitis and bronchiolitis obliterans. For diagnosis of CAV 2 infection either cultivation of the virus in primary dog kidney cells or immunofluorescence assay (Buonavoglia and Martella, 2007) or polymerase chain reaction (Hu et al., 2001) or virus precipitation or hemagglutination inhibition or complement fixation or agar gel diffusion or virus neutralization tests have been used.

Another minor cause of kennel cough is Canine parainfluenza virus (Erles et al., 2004). For the detection of virus, hemadsorption or immunofluorescence, RT–PCR (Erles et al., 2004), hemagglutination inhibition and the virus neutralization tests have been demonstrated.

Rarely Canine Herpes virus (Kawakami et al., 2010), mammalian Reo virus, Canine distemper virus and canine respiratory corona virus, S. equi subsp. zooepidemicus and Mycoplasma cynos (Chalker et al., 2003) may also be cause of kennel cough in dogs.

Bordetellosis comprises of two clinical forms. The most common uncomplicated form is associated with dry hacking cough, gagging and retching behavior in dogs. The other form, the complicated form characterized by wet cough, is common in puppies or immuno–compromised dogs. The disease is associated with mucoid discharges and signs of systemic infection including pyrexia, anorexia, chorioretinitis, vomiting and diarrhoea leading to death of the pup. Incubation period ranges between 1 to 8 days showing clinical signs for 1–2 weeks. Infected dogs may shed the pathogen for 2–3 months after clinical recovery (Edinboro et al., 2004).

The genus Bordetella, belonging to family Alcaligenaceae (Gerlach et al., 2001), is comprised of nine species as B. bronchiseptica, B. pertussis, B. parapertussis (human), B. parapertussis (ovine), B. hinzii, B. aviumr , B. holmseii, B. trematum and B. petrii (Mattoo and Cherry, 2005). Bordetella bronchiseptica, B. pertussis, B. parapertussis and B. holmesii and have been associated with zoonotic respiratory infections (Cotter and Miller, 2001). Bordetella bronchiseptica had been known by many names earlier viz., Bacillus bronchicanis, Alcaligenes bronchisepticus, Brucella bronchiseptica, Alcaligenes bronchicanis, Haemophilus bronchisepticus and finally Moreno–Lopez named it as B. bronchiseptica.

Besides kennel cough in dogs, B. bronchiseptica also causes atrophic rhinitis in pigs (Shome et al., 2006), snuffles in rabbits, suppurative bronchopneumonia in cats, suppurative necrotizing bronchopneumonia in guinea pigs, atrophic rhinitis in rats and respiratory infections in humans. Though B. bronchiseptica is a recognized cause of kennel cough throughout the world (Durgut et al., 2003), in India it is only a suspected cause of kennel cough and has rarely been isolated from dogs (Bonde et al., 1990; Reddy et al., 2003; Bhardwaj, 2013a; Bhardwaj et al., 2013).

Bordetella LPS is a highly immunogenic, major constituent of the outer cell membrane and an important bacterial defense against host immune responses including antibodies, complement, antimicrobial peptides, and surfactants. The LPS of B. bronchiseptica is highly charged due to the presence of uronic acids in the ‘O’ specific side chains, thus it is capable of masking negative charges present on the membranes to prevent an efficient membrane attack by the cationic antibacterial peptides (Preston and Maskell, 2001; Pilione et al., 2004; Schaeffer et al., 2004; Goebel et al., 2008).

The genus Bordetella exhibits several virulence factors such as adhesins, filamentous hemagglutinin, pertactin and fimbriae as well as the cytotoxic factor adenylate cyclase toxin (ACT), which differ among different species. The expression of these virulence factors is controlled by the BvgAS two–component system in response to certain environmental stimuli. The regulatory system is characterized by antigenic modulation and phase variation. The antigenic modulation decides the activation and repression of synthesis of virulence factors which are dependent on growth conditions whereas phase variation is the result of mutations in vir gene which also modulates virulence under appropriate cultural conditions.

Filamentous hemagglutinin, a 220 kDa rod shaped protein encoded by fhaB gene, has been found to be associated with virulence (Mattoo and Cherry, 2005). However, adhesion proteins (Edwards et al., 2005) and pertactin (Sebaihia et al., 2006) are considered as important virulence factors for Bordetella species. Out of six major fimbrial subunits fim2 and fim3 fimbrial subunit genes are responsible for bordetellae adhesion to host cells (Mattoo and Cherry, 2005). The tracheal cytotoxin TCT expressed by B. aviumr , a toxin lethal for tracheal cells and degenerating bones is also present in B. bronchiseptica. The adenylate cyclase toxin (ACT) also acts as an important factor for virulence of Bordetella strains (Masin et al., 2006; Vojtova et al., 2006; Buboltz et al., 2008). Besides all of these toxins, dermonecrotic toxin (DNT), a heat labile intracellular 160 kDa protein of B. bronchiseptica may play a role in the production of respiratory disease in dogs (Hoffmann and Schmidt, 2004; Masin et al., 2006).

The diagnosis of bordetellosis depends primarily on the isolation of the B. bronchiseptica followed by the identification of the organism by biochemical, serological and molecular methods.

Bordetella species grow readily on blood agar, Bordet–Gengou agar, Smith–Baskerville culture media and MacConkey agar at optimum temperature of 37^oC. The room temperature incubation should be avoided because of overgrowth of other bacteria suppressing B. bronchiseptica multiplication. In case of B. pertussis it was showed that colony numbers decreased by 75% on transportation of specimens at refrigerated temperature (4 ^oC).

Bordetella bronchiseptica strains have phase 1 (smooth, small, convex and virulent) and phase 4 (rugged, large, and non–virulent) colonies. Biochemically, all strains are positive for oxidase, catalase and citrate utilization (Denes et al., 2006) and are negative for fermentation of any sugar, production of gelatinase, DNase, indole and H2S.

Isolation of B. bronchiseptica from different sites of respiratory tract of dogs (Gonazalez et al., 2006) and have widely been reported. But, in India the pathogen is rarely isolated from dogs (Bhardwaj, 2013; Bhardwaj et al., 2013). However, in India it has been isolated several times from pigs either associated with atrophic rhinitis or from healthy stocks (Shome et al., 2006; Mazumder et al., 2012; Kumar, 2013). But attempts have been made to isolate the organism from dogs (Bonde et al., 1990; Reddy et al., 2003). Bhardwaj (2013) reported isolation of B. bronchiseptica from an apparently healthy dog but not from the dogs suffereing from kennel cough. They used transport media (buffered peptone water with 0.8% agar and horse serum) for transportation of nasal swabs and throat swabs. The isolate of B. bronchiseptica was sensitive to etrapenem, azithromycin, imipenam, ciprofloxacin, gentamicin, piperacillin+tazobactum, tetracycline polymixin–B and nalidixic whereas resistant to vancomycin, lincomycin, penicillin, cefotaxime, amoxicillin, ceftazidime, nitrofurantoin, ceftriaxone and amoxicillin+ clavulanic acid (Bhardwaj et al., 2013).

Due to difficulty in isolation, serological tests are often considered good adjunct to facilitate diagnosis of kennel cough. Several serological tests have been developed, standardized and evaluated for detection of Bordetella antibodies for rapid assessment of prevalence of the infection in laboratory animals and other livestock. Commonly employed serological tests include tube agglutination, indirect haemagglutination (Bonde et al., 1990), micro–agglutination test (Denes, 2005; Kumar, 2013) and ELISA (Ellis et al., 2001; Kumar, 2013). In a study on 136 serum samples revealed that MAT titres positively correlate with kennel cough symptoms and were high in sick dogs than in apparently healthy dogs (Bhardwaj, 2013; Bhardwaj et al., 2013). High Bordetella agglutinin titre (>128) in clinically diseased dogs indicates that Bordetella infection might be an important pathogen for kennel cough. Bhardwaj et al. (2013) also used whole cell ELISA (wcELISA) and precipitated protein ELISA (ppELISA) and found wcELISA much superior than ppELISA as an aid for diagnosis of bordetellosis in dogs.

Isolation and identification of B. bronchiseptica is a time consuming process and serological techniques do not have good specificity. As a result, polymerase chain reaction (PCR) has been exploited to attain a fast and accurate detection of Bordetella in clinical samples. For the identification of B. bronchiseptica, genus specific and species specific PCRs (Hozbor et al., 1999; Coutinho et al., 2009; Register and DeJong, 2006; Koidl et al., 2007; Register and Nicholson, 2007; Xin et al., 2008; Stępniewska and Markowska–Daniel, 2010; Roorda et al., 2012; Kumar, 2013; Bhardwaj et al., 2013) have been used. Ribotyping and RAPD analysis are already combined by a few researchers to evaluate genetic relatedness among canine B. bronchiseptica isolates.

Bhardwaj et al. (2013) screened 147 dogs using genus and species specific multiplex PCR but could not establish any good association between clinical disease and detection of B. bronchiseptica by PCR. The genus specific primers used are A643Bbalc–F and A856Bbalc–R (Table 1). Species specific primers used by different researchers (Table 2) have been designed either from fim or fla gene sequences.

There are only few reports on plasmid profiling of B. bronchiseptica (Mazumder et al., 2012; Kumar, 2013). Bhardwaj et al. (2013) could identify single plasmid (Molecular weight, 50 MDa) from a single isolate of B. bronchiseptica while several isolates from pigs have been reported to harbor multiple plasmids (Mazumder et al., 2012; Kumar, 2013).

Vaccination plays an important role in the prevention of infectious canine tracheobronchitis (Datz, 2003a). Live avirulent intranasal vaccines that combine B. bronchiseptica with canine parainfluenza virus, and canine adenovirus– 2, have been reported to confer better protection than B. bronchiseptica vaccines alone against kennel cough. Datz (2003b) reviewed modified live vaccines available worldwide for kennel cough intended for intranasal administration containing live, avirulent B. bronchiseptica with or without canine parainfluenza virus and canine adenovirus type 2. Intranasal as well as injectable vaccines of B. bronchiseptica may afford substantial protection against B. bronchiseptica (Ellis et al., 2001). In India, Reddy et al. (2003) prepared inactivated aluminium hyrdroxide gel B. bronchiseptica vaccine which protected vaccinated mice against homologous B. bronchiseptica challenge.

Bordetella bronchiseptica infection in humans is rare but has been documented in both healthy and immuno–suppressed individuals (Hewlett, 2000; Schneider and Gross, 2001; Lo et al., 2001). Intranasal vaccination in dogs may be one of the major risk factor for humans. Pneumonia, sepsis, and death have been reported after infection in human beings (Shimoni et al., 2000).

CONCLUSIONS

Kennel cough is one of the severe respiratory tract infections of dogs mostly in close confinements. Being a multi–etiological disease, the identification of organism is a bit difficult. In developing countries including India, this disease has not been given much importance due to other important health problems in dogs and thus majority of bordetellosis cases might remain undiagnosed. This disease has major importance for dog breeders and army stations where they keep dogs in close association. This disease is of special concern due to its contagiousness. Due to difficulty in diagnosis, some rapid, reliable and economical tests need to be developed and evaluated to reveal its epidemiology in developing countries. Though PCR has been found to be the most rapid, sensitive (up to 5 CFU) and specific method to detect B. bronchiseptica, its field version needs evaluation. The MAT a well–evaluated test is better diagnostic test than ELISA but lack the desired sensitivity and specificity. Moreover, attempts for development of risk free vaccines are also needed to combat bordetellosis in dogs.

REFERENCES

Bhardwaj M (2013). Evaluation of molecular and serological techniques for diagnosis of bordetellosis in dogs. M.V.Sc. thesis, Indian Veterinary Research Institute, Izatnagar, India.

Bhardwaj M, Singh BR, Kumar S and Pawde AM (2013). Poor association of Bordetella bronchiseptica infection with kennel cough in dogs in northern India. Universal J. Microbiol. Res. 1: 10–14.

Bonde AV, Sherikar AA and Mulbagal AN (1990). Seroprevalence of Bordetella bronchiseptica and canine parainfluenza virus type 2 in dogs in Bombay. J. Bombay Vet. Col. 2(2): 79–82.

Bradley T and Kingnov R (2012). The dog economy is global but what is the world's true canine capital? The Atlantic. http://www.theatlantic.com/business/archive/2012/11/the-dog-economy-is-global-but-what-is-the-worlds-true-canine-capital/265155/

Buboltz AM, Nicholson TL, Parette MR, Hester SE, Parkhill J and Harvill ET (2008). Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J. Bacteriol. 190(15): 5502–5511.
http://dx.doi.org/10.1128/JB.00226-08
PMid:18556799 PMCid:PMC2493278

Bulut O, Yapici O, Avci O, Simsek A, Atli K, Dik I, Yavru S, Hasircioglu S, Kale M and Mamak N (2013). The Serological and Virological Investigation of Canine Adenovirus Infection on the Dogs. Scientific World J. http://dx.doi.org/10.1155/2013/587024.
http://dx.doi.org/10.1155/2013/587024

Buonavoglia C and Martella V (2007). Canine respiratory viruses. Vet Res. 38:355–73.
http://dx.doi.org/10.1051/vetres:2006058
PMid:17296161

Chalker VJ, Brooks HW and Brownlie J (2003). The association of Streptococcus equi sub sp. zooepidemicus with canine infectious respiratory disease. Vet. Microbiol. 95: 149– 156.
http://dx.doi.org/10.1016/S0378-1135(03)00155-X

Chalker VJ, Owen WM, Paterson C, Barker E, Brooks H, Rycroft AN and Brownlie J (2004). Mycoplasmas associated with canine infectious respiratory disease. Microbiol. 150: 3491–3497.
http://dx.doi.org/10.1099/mic.0.26848-0
PMid:15470126

Cotter PA and Miller JF (2001). Bordetella. In: Principles of bacterial pathogenesis. E. A. Groisman (ed.), London, UK Academic Press. 619–674.
http://dx.doi.org/10.1016/B978-012304220-0/50014-5

Coutinho T A, Bernardi M L, Cardoso MRI, Borowski S M, Moreno A M and Barcellos DESN (2009). Performance of transport and selective media for swine Bordetella bronchiseptica recovery and it comparison to polymerase chain reaction detection. Braz. J. Microbiol. 40: 470–479.
http://dx.doi.org/10.1590/S1517-83822009000300009
PMid:24031390 PMCid:PMC3768553

Datz C (2003a). Bordetella infections in dogs and cats: Pathogenesis, clinical signs, and diagnosis. Compend. Contin. Educ. Pract. Vet. 25: 896–901.

Datz C (2003b). Bordetella infections in dogs and cats: Treatment and prevention. Compend.Contin. Educ. Pract. Vet. 25: 902–914.

Denes AL (2005). Investigation regarding isolation, identification and carriage of Bordetella bronchiseptica in pigs, horses and dogs. Bulletin USAMV Cluj–Napoca, Seria Med. Vet. 62:109–112.

Denes AL, Rapuntean Gh, Cosmina Cuc, FiN N, Nadas G and Calina D (2006). Biochemical tests used for identification of Bordetella bronchiseptica. Buletinul USAMV–CN. 63: 67–70.

Durgut R, Borku MK, Ozkok S, Pekkaya S, Guzel M and Ozkanlar YE (2003). Kennel cough syndrome of dogs observed in Ankara province. Indian Vet. J. 80(8): 743–745.

Edinboro CH, Ward MP and Glickman LT (2004). A placebo–controlled trial of two intranasal vaccines to prevent tracheobronchitis (kennel cough) in dogs entering a humane shelter. Prev. Vet. Med. 62: 89–99.
http://dx.doi.org/10.1016/j.prevetmed.2003.10.001
PMid:15156996

Edwards JA, Groathouse NA and Boitano S (2005). Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A. Infect Immun. 73(6):3618–26.
http://dx.doi.org/10.1128/IAI.73.6.3618-3626.2005
PMid:15908391 PMCid:PMC1111863

Ellis JA, Haines DM, West KH, Burr JH, Dayton A, Townsend HGG, Kanara EW, Konoby C, Crichlow A, Martin K and Headrick G (2001). Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs. J. Am. Vet. Med. Assoc. 218:367–375.
http://dx.doi.org/10.2460/javma.2001.218.367
PMid:11201562

Erles K, Dubovi EJ, Brooks HW and Brownlie J (2004). Longitudinal study of viruses associated with canine infectious respiratory disease. J. Clin. Microbiol. 42:4524–4529.
http://dx.doi.org/10.1128/JCM.42.10.4524-4529.2004
PMid:15472304 PMCid:PMC522361

Gerlach G, von Wintzingerode F, Middendorf B and Gross R (2001). Evolutionary trendsin the genus Bordetella. Microbes Infect. 3: 61–72.
http://dx.doi.org/10.1016/S1286-4579(00)01353-8

Goebel EM, Wolfe DN, Elder K, Stibitz S and Harvill ET (2008). 'O' antigen protects Bordetella parapertussis from complement. Infect. Immun. 76: 1774–1780.
http://dx.doi.org/10.1128/IAI.01629-07
PMid:18285500 PMCid:PMC2292887

Gonzalez GM, Rosales ME, Morales, GB and Crespo JAM (2006). Isolation and characterization of Bordetella bronchiseptica strains from canine origin. Vet Mex. 37(3): 313–332.

Hewlett EL (2000). Bordetella species. In: Principles and practice of infectious diseases.Mandell, G.L., Bennett, J.E., Dolin, R., eds. Philadelphia: Churchill Livingston, 2414–22 p.

Hoffmann C and Schmidt G (2004). CNF and DNT. Rev. Physiol. Biochem. Pharmacol. 152: 49–63.
http://dx.doi.org/10.1007/s10254-004-0026-4
PMid:15549605

Hozbor D, Fouque F and Guiso N (1999). Detection of Bordetella bronchiseptica by polymerase chain reaction. Res. Microbiol. 150: 333–341.
http://dx.doi.org/10.1016/S0923-2508(99)80059-X

Hu RL, Huang G, Qiu W, Zhong ZH, Xia XZ and Yin Z (2001). Detection and differentiation of CAV–1 and CAV–2 by polymerase chain reaction, Vet. Res. Commun. 25:77–84.
http://dx.doi.org/10.1023/A:1006417203856
PMid:11214675

Kawakami K, Ogawa H, Maeda K, Imai A, Ohashi E, Matsunaga S, Tohya Y, Ohshima T andMochizuki M (2010). Nosocomial Outbreak of Serious Canine Infectious Tracheobronchitis (Kennel Cough) Caused by Canine Herpes virus Infection. J Clin Microbiol. 48(4): 1176–1181.
http://dx.doi.org/10.1128/JCM.02128-09
PMid:20107103 PMCid:PMC2849577

Koidl C, Bozic M, Burmeister A, Hess M, Marth E and Kessler HH (2007). Detection and Differentiation of Bordetella spp. by Real Time PCR. J. Clin. Microbiol. 45(2): 347–350.
http://dx.doi.org/10.1128/JCM.01303-06
PMid:17151212 PMCid:PMC1829002

Kumar S (2013). Studies on occurrence of Bordetella infection in pigs. M.V.Sc. thesis, Indian Veterinary Research Institute, Izatnagar, India.

Lennox AM and Kelleher S (2009). Bacterial and parasitic diseases of rabbits. Veterinary Clinics of North America: Exotic Animal Practice. 12(3): 519–530.
http://dx.doi.org/10.1016/j.cvex.2009.06.004
PMid:19732707

Lo Re V, Brennan PJ, Wadlin J, Weaver R and Nachamkin I (2001). Infected branchial cleft cyst due to Bordetella bronchiseptica in an immunocompetent patient. J. Clin. Microbiol. 39: 4210–2412.
http://dx.doi.org/10.1128/JCM.39.11.4210-4212.2001
PMid:11682564 PMCid:PMC88521

Masin J, Sebo P and Locht C (2006). Bordetella protein toxins. In: The comprehensive sourcebook of bacterial protein toxins. Alouf, J. E. and Popoff, M. R. (eds.). SaDiego, CA: Academic Press. 291–309 p.

Mattoo S and Cherry JD (2005). Molecular pathogenesis, epidemiology and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18: 326–382.
http://dx.doi.org/10.1128/CMR.18.2.326-382.2005
PMid:15831828 PMCid:PMC1082800

Mazumder Y, Das A, Kar D, Shome B R, Dutta BK and Rahman H (2012). Isolation of Bordetella bronchiseptica from pigs in North East India. J. Anim. Sci. Adv. 2(4): 396–406.

Pilione MR, Pishko EJ, Preston A, Maskell DJ and Harvill ET (2004). pagP is required for resistance to antibody – mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect. Immun. 72: 2837–2842.
http://dx.doi.org/10.1128/IAI.72.5.2837-2842.2004
PMid:15102794 PMCid:PMC387902

Preston A and Maskell D (2001). The molecular genetics and role in infection of lipopolysaccharide biosynthesis in the Bordetellae. J. Endotoxin. Res. 7: 251– 261.
http://dx.doi.org/10.1179/096805101101532765
http://dx.doi.org/10.1177/09680519010070040601
PMid:11717578

Reddy GS, Sharma MSR and Srinivasan VA (2003). Efficacy of inactivated Bordetella bronchiseptica vaccine in mice and dogs. Indian Vet. J. 80(1): 1–2.

Register KB and DeJong KD (2006). Analytical verification of multiplex PCR for identification of Pasteurella multocida and Bordetella bronchiseptica from swine. Vet. Microbiol. 117: 201– 210.
http://dx.doi.org/10.1016/j.vetmic.2006.05.003
PMid:16782287

Register KB and Nicholson TL (2007). Misidentification of Bordetella bronchiseptica as Bordetella pertussis using a newly described real–time PCR targeting the pertactin gene. J. Med. Microbiol. 56: 1608–1610.
http://dx.doi.org/10.1099/jmm.0.47511-0
PMid:18033827

Roorda L, Buitenwerf J, Ossewaarde JM and van der Zee A (2011). A real–time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three insertion sequence elements. BMC Res. Notes. 4: 11.
http://dx.doi.org/10.1186/1756-0500-4-11
PMid:21255383 PMCid:PMC3035196

Rycroft AN, Tsounakou E and Chalker V (2007). Serological evidence of Mycoplasma cynos infection in canine infectious respiratory disease. Vet. Microbiol. 120: 358– 362.
http://dx.doi.org/10.1016/j.vetmic.2006.11.011
PMid:17184934

Schaeffer LM, McCormack FX, Wu H and Weiss AA (2004). Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect. Immun. 72: 7124–7130.
http://dx.doi.org/10.1128/IAI.72.12.7124-7130.2004
PMid:15557636 PMCid:PMC529120

Schneider B. and Gross R (2001). Bordetella pertussis: Increasing problems with a wellknown pathogen and its relatives. In: Emerging bacterial pathogens. Muhldorfer, I., Schafer, K.P., eds. Basel, Switzerland: S. Karger Publishing. 123–136 p.

Sebaihia M, Preston A, Maskell DJ, Kuzmiak H, Connell TD, King ND et al. (2006). Comparison of the genome sequence of the poultry pathogen Bordetella avium with those of B. bronchiseptica, B. pertussis and B. parapertussis reveals extensive diversity in surface structures associated with host interaction. J. Bacteriol. 188: 6002–6015.
http://dx.doi.org/10.1128/JB.01927-05
PMid:16885469 PMCid:PMC1540077

Shimoni Z, Niven M, Mosenkis M and Greif J (2000). Fatal pneumonia due to Bordetella bronchiseptica. Isr. Med. Assoc. J. 2: 402–403.
PMid:10892400

Shome BR, Shome R, Rahman H, Mazumder Y, Das A, Rahman MM and Bujarbaruah KM (2006). Characterization of Bordetella bronchiseptica associated with atrophic rhinitis outbreak in pigs. Indian J. Anim. Sci. 76(6): 433–436.

Stępniewska K and Markowska DI (2010). Evaluation of PCR test for detection of dermonecrotoxin of Bordetella bronchiseptica. Bull. Vet. Inst. Pulawy. 54: 495– 499.

Vojtova J, Kamanova J and Sebo P (2006). Bordetella adenylate cyclase toxin: A swift saboteur of host defense. Curr. Opin. Microbiol. 9: 69–75.
http://dx.doi.org/10.1016/j.mib.2005.12.011
PMid:16406775

Xin W, ShiFeng Y and Fang W (2008). Development and application of PCR assay for detection of Bordetella bronchiseptica in rabbits. Pathol. Hyg. 9th World Rabbit Congress: 879–1179.